SCMOM 2012_Q Therapeutics
Q Therapeutics is harnessing the power of stem cells to treat debilitating diseases of the central nervous system, which encompass a broad range of diseases including ALS, multiple sclerosis, spinal cord injury, stroke, cerebral palsy, Parkinson #39;s and Alzheimer #39;s diseases. Q-Cells® function as #39;mini-factories #39; to repair neurons, utilizing multiple pathways including myelination, growth factor production and toxin removal. By utilizing the natural support and repair mechanisms of healthy CNS, safety and efficacy are enhanced. Q has a strong proprietary position with 16 patents issued and 12 pending. Our products address a multi-billion dollar market opportunity for which traditional drugs have failed. http://www.qthera.com Presenter: Deborah Eppstein, Ph.D., President and CEO, Q TherapeuticsFrom:AllianceRegenMedViews:4 1ratingsTime:10:47More inScience Technology
Excerpt from:
SCMOM 2012_Q Therapeutics - Video